找回密碼
 To register

QQ登錄

只需一步,快速開始

掃一掃,訪問微社區(qū)

打印 上一主題 下一主題

Titlebook: FDA Bioequivalence Standards; Lawrence X. Yu,Bing V. Li Book 2014 The United States Government 2014 ANDA.bioequivalence.narrow therapeutic

[復制鏈接]
查看: 49723|回復: 56
樓主
發(fā)表于 2025-3-21 19:49:40 | 只看該作者 |倒序瀏覽 |閱讀模式
書目名稱FDA Bioequivalence Standards
編輯Lawrence X. Yu,Bing V. Li
視頻videohttp://file.papertrans.cn/341/340036/340036.mp4
概述Covers the fundamentals as well as the most up-to-date progress in bioequivalence standards, which are critical to new and generic development and regulation.Discusses the current best practices in bi
叢書名稱AAPS Advances in the Pharmaceutical Sciences Series
圖書封面Titlebook: FDA Bioequivalence Standards;  Lawrence X. Yu,Bing V. Li Book 2014 The United States Government 2014 ANDA.bioequivalence.narrow therapeutic
描述.This comprehensive reference provides an in-depth discussion on state-of-the-art regulatory science in bioequivalence. In sixteen chapters, the volume explores a broad range of topics pertaining to bioequivalence, including its origin and principles, statistical considerations, food effect studies, conditions for waivers of bioequivalence studies, Biopharmaceutics Classification Systems, Biopharmaceutics Drug Disposition Classification System, bioequivalence modeling/simulation and best practices in bioanalysis. It also discusses bioequivalence studies with pharmacodynamic and clinical endpoints as well as bioequivalence approaches for highly variable drugs, narrow therapeutic index drugs, liposomes, locally acting gastrointestinal drug products, topical products and nasal and inhalation products..FDA Bioequivalence Standards. is written by FDA regulatory scientists who develop regulatory policies and conduct regulatory assessment of bioequivalence. As such, both practical case studies and fundamental science are highlighted in these chapters.. .The book is a valuable resource for scientists who work in the pharmaceutical industry, regulatory agencies and academia as well as under
出版日期Book 2014
關鍵詞ANDA; bioequivalence; narrow therapeutic window index drugs; regulations; simulation
版次1
doihttps://doi.org/10.1007/978-1-4939-1252-0
isbn_softcover978-1-4939-5558-9
isbn_ebook978-1-4939-1252-0Series ISSN 2210-7371 Series E-ISSN 2210-738X
issn_series 2210-7371
copyrightThe United States Government 2014
The information of publication is updating

書目名稱FDA Bioequivalence Standards影響因子(影響力)




書目名稱FDA Bioequivalence Standards影響因子(影響力)學科排名




書目名稱FDA Bioequivalence Standards網(wǎng)絡公開度




書目名稱FDA Bioequivalence Standards網(wǎng)絡公開度學科排名




書目名稱FDA Bioequivalence Standards被引頻次




書目名稱FDA Bioequivalence Standards被引頻次學科排名




書目名稱FDA Bioequivalence Standards年度引用




書目名稱FDA Bioequivalence Standards年度引用學科排名




書目名稱FDA Bioequivalence Standards讀者反饋




書目名稱FDA Bioequivalence Standards讀者反饋學科排名




單選投票, 共有 0 人參與投票
 

0票 0%

Perfect with Aesthetics

 

0票 0%

Better Implies Difficulty

 

0票 0%

Good and Satisfactory

 

0票 0%

Adverse Performance

 

0票 0%

Disdainful Garbage

您所在的用戶組沒有投票權限
沙發(fā)
發(fā)表于 2025-3-21 22:25:23 | 只看該作者
第140036主題貼--第2樓 (沙發(fā))
板凳
發(fā)表于 2025-3-22 03:22:45 | 只看該作者
板凳
地板
發(fā)表于 2025-3-22 05:06:08 | 只看該作者
第4樓
5#
發(fā)表于 2025-3-22 10:00:03 | 只看該作者
5樓
6#
發(fā)表于 2025-3-22 16:21:11 | 只看該作者
6樓
7#
發(fā)表于 2025-3-22 20:51:38 | 只看該作者
7樓
8#
發(fā)表于 2025-3-22 22:22:53 | 只看該作者
8樓
9#
發(fā)表于 2025-3-23 04:16:09 | 只看該作者
9樓
10#
發(fā)表于 2025-3-23 08:48:57 | 只看該作者
10樓
 關于派博傳思  派博傳思旗下網(wǎng)站  友情鏈接
派博傳思介紹 公司地理位置 論文服務流程 影響因子官網(wǎng) 吾愛論文網(wǎng) 大講堂 北京大學 Oxford Uni. Harvard Uni.
發(fā)展歷史沿革 期刊點評 投稿經(jīng)驗總結 SCIENCEGARD IMPACTFACTOR 派博系數(shù) 清華大學 Yale Uni. Stanford Uni.
QQ|Archiver|手機版|小黑屋| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-8 12:03
Copyright © 2001-2015 派博傳思   京公網(wǎng)安備110108008328 版權所有 All rights reserved
快速回復 返回頂部 返回列表
巴林右旗| 澜沧| 辽中县| 宜宾市| 苗栗县| 新余市| 奎屯市| 大冶市| 嘉善县| 高台县| 白沙| 尼勒克县| 孟连| 紫阳县| 南投县| 当雄县| 吐鲁番市| 文山县| 改则县| 梧州市| 黎川县| 丽水市| 微山县| 荔浦县| 长宁区| 濉溪县| 辛集市| 江城| 安达市| 永新县| 家居| 曲靖市| 余姚市| 上思县| 施秉县| 伊金霍洛旗| 修武县| 鄢陵县| 石台县| 东辽县| 松江区|